Thus, TSPO PET imaging is, nowadays, widely recognized as a useful biomarker of activated microglia involvement in CNS disorders that assisted in the early detection of neuroinflammation, monitor the severity and progression of the neurodegenerative diseases, and help to consider the effectiveness of emerging CNS therapies aimed at decreasing neuroinflammation. This evidence concerns the gene TSPO and neurodegenerative disease.